Skip to content
  • Home
  • contact-rita@ern-net.eu
  • News
  • FAQ
  • Contact
  • Facebook
  • LinkedIn
  • Twitter
ERN-RITA

ERN-RITA

European Reference Network for Immunodeficiency, Autoinflammatory, Autimmune and Pediatric Rheumatic diseases Diseases

  • Reference centers
  • Disease information
  • Virtual consultations
  • Activities
    • Webinars
    • Working Groups
  • Patients
    • ERNs and ePAGs
    • RIPAG
    • Patient Organisations within the EU
  • About
    • RITA: A Unique Opportunity
    • Mission, Goals and Objectives
    • Governance
    • RITA Membership
    • Scientific societies, stakeholders
    • About ERNS
  • Rare diseases
  • Primary immunodeficiencies (PID)
  • Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells
Rare diseases
  • Pediatric Rheumatic diseases (PR)
    • Juvenile Arthritis
    • Miscellaneous
    • Systemic autoimmune disease
    • Bone disease
    • Paediatric vasculitis
  • Autoimmune diseases (AI)
    • Autoimmune systemic vasculitis adult and paediatric
    • Autoimmune Neuroinflammation Adult and Paediatric
  • Autoinflammatory disorders (AID)
    • Defects affecting the inflammasome
    • Non inflammasome-related conditions
    • Type 1 Interferonopathies
    • Monogenic Inflammatory bowel diseases
    • Miscellaneous
  • Primary immunodeficiencies (PID)
    • T−B+ Severe Combined Immunodeficiency (SCID)
    • T−B− SCID DNA recombination defects
    • Combined immunodeficiencies generally less profound than severe combined immunodeficiency
    • Congenital thrombocytopenia
    • DNA repair defects (other than those in group 1)
    • Thymic defects with additional congenital anomalies
    • Immune-osseous dysplasias
    • Hyper-IgE syndromes (HIES)
    • Dyskeratosis congenita (DKC) with bone marrow failure and dysfunctional telomere maintenance
    • Defects of Vitamin B12 and Folate metabolism
    • Anhidrotic ectodermaldysplasia with immunodeficiency (EDA-ID)
    • Calcium channel defects
    • Other defects
    • Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells
    • Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells
    • Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells
    • Isotype or light chain deficiencies with generally normal numbers of B cells
    • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes without hypopigmentation
    • Familial hemophagocytic lymphohistiocytosis (FHL) syndromes with hypopigmentation
    • T regulatory cells genetic defects
    • Autoimmunity with or without lymphoproliferation
    • Autoimmune lymphoproliferative syndrome (ALPS)
    • Immune dysregulation with colitis
    • Type 1 Interferonopathies
    • Congenital neutropenias
    • Defects of Motility
    • Defects of Respiratory Burst
    • Medelian Susceptibility to mycobacterial disease (MSMD)
    • Epidermodysplasia verruciformis
    • Predisposition to severe viral infection
    • Herpes simplex encephalitis (HSE)
    • Predisposition to invasive fungal diseases
    • Chronic mucocutaneous candidiasis (CMC)
    • TLR signaling pathway deficiency

Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells

Disease information Hide
LinksIPOPI
Patient organisations Show
LinksIPOPI - International Patient Organisation for Primary Immunodeficiencies

Diseases

TTC37 deficiencyDisease detail TRNT1 deficiencyDisease detail MOGS deficiencyDisease detail NFKB2 deficiencyDisease detail TWEAK deficiencyDisease detail BAFF receptor deficiencyDisease detail TACI deficiencyDisease detail CD21 deficiencyDisease detail CD20 deficiencyDisease detail CD81 deficiencyDisease detail CD19 deficiencyDisease detail Common variable immunodeficiency disordersDisease detail
RITA Newsletters

Scientific societies & stakeholders

Network coordination

UMC Utrecht
Heidelberglaan 100
3584 CX Utrecht
Netherlands
VAT NL004205315B01

Follow us & get in touch:

The contents of this webpage are the sole responsibility of ERN-RITA and do not necessarily reflect the opinion of the European Union. 

© 2019 ERN RITA. All rights reserved. The RITA logo was created by Monica Pietsch.